Rogue proliferation versus restorative protection: where do we draw the line for Wnt and forkhead signaling? - PubMed (original) (raw)
Review
Rogue proliferation versus restorative protection: where do we draw the line for Wnt and forkhead signaling?
Kenneth Maiese et al. Expert Opin Ther Targets. 2008 Jul.
Abstract
Background: Disease entities such as diabetes, neurodegeneration and cardiovascular disorders affect a significant portion of the world's population.
Objective: Given that cellular survival and longevity in multiple disorders are tied to oxidative stress, apoptotic cell injury and immune system deregulation, the development of robust therapeutic strategies rests heavily upon the ability to balance each of these parameters.
Methods: Here we discuss two exciting signaling pathways, namely Wnt and mammalian forkhead transcription factors predominantly of the O class superfamily, which can share integrated cytoprotective pathways during oxidative stress but may also adversely influence cellular survival and promote cancer cell proliferation.
Conclusion: Future investigations must elucidate the cellular determinants that govern the ability of Wnt and forkhead proteins to promote cellular longevity and possible disease remission but also allow for detrimental biological consequences and clinical compromise.
Conflict of interest statement
Declaration of interest
The authors declare no conflicts of interest and have received no payment for preparation of this manuscript.
Figures
Figure 1. Wnt signaling is mediated through the β-catenin (canonical) and the calcium (non-canonical) pathways
A representative schematic for the pathways is shown. The canonical Wnt signaling pathway is referred to as the Wnt/β-catenin pathway since it can regulate β-catenin. All Wnt signaling pathways are initiated by interaction of Wnt proteins with Frizzled (FZD) receptors. Once Wnt protein binds to the FZD receptor and the co-receptor low-density lipoprotein receptor-related protein (LRP)-5/6, this is followed by recruitment of Dishevelled. Dishevelled can inhibit glycogen synthase kinase (GSK-3β) activity. The non-canonical or calcium Wnt signaling pathway has two intracellular signaling cascades that consist of the Wnt/Ca2+ pathway and the Wnt/planar cell polarity (PCP) pathway. In the Wnt/Ca2+ pathway, Wnt protein binds to FZD receptors on the cell surface resulting in several cellular processes that can involve stimulation of heterotrimeric G proteins and increased intracellular Ca2+ release. Yet, the distinction between these pathways is sometimes not distinct and may involve non-canonical pathways, such as Wnt5a, that antagonize canonical pathways by leading to the degradation of β-catenin. Lef: Lymphoid enhancer-binding factor; Tcf: T cell factor.
Figure 2. FoxO proteins function during oxidative stress to determine cell proliferation, apoptosis, immune system function, longevity, and tumorigenesis
During stimuli such as oxidative stress, FoxO can be linked to a number of pathways that directly modulate FoxO activity, such as protein kinase B (Akt), the IκB kinase (IKK) pathway, and NF-κB, or that require FoxO to ultimately determine several cellular processes such as cell cycle regulation, apoptosis, immune system modulation, and malignancy.
Similar articles
- Diabetes mellitus: channeling care through cellular discovery.
Maiese K, Shang YC, Chong ZZ, Hou J. Maiese K, et al. Curr Neurovasc Res. 2010 Feb;7(1):59-64. doi: 10.2174/156720210790820217. Curr Neurovasc Res. 2010. PMID: 20158461 Free PMC article. - A fork in the path: Developing therapeutic inroads with FoxO proteins.
Maiese K, Hou J, Chong ZZ, Shang YC. Maiese K, et al. Oxid Med Cell Longev. 2009 Jul-Aug;2(3):119-29. doi: 10.4161/oxim.2.3.8916. Oxid Med Cell Longev. 2009. PMID: 20592766 Free PMC article. Review. - A "FOXO" in sight: targeting Foxo proteins from conception to cancer.
Maiese K, Chong ZZ, Shang YC, Hou J. Maiese K, et al. Med Res Rev. 2009 May;29(3):395-418. doi: 10.1002/med.20139. Med Res Rev. 2009. PMID: 18985696 Free PMC article. Review. - OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.
Maiese K, Chong ZZ, Shang YC. Maiese K, et al. Trends Mol Med. 2008 May;14(5):219-27. doi: 10.1016/j.molmed.2008.03.002. Epub 2008 Apr 9. Trends Mol Med. 2008. PMID: 18403263 Free PMC article. Review. - Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress.
Chong ZZ, Li F, Maiese K. Chong ZZ, et al. Curr Neurovasc Res. 2006 May;3(2):107-17. doi: 10.2174/156720206776875830. Curr Neurovasc Res. 2006. PMID: 16719794 Free PMC article.
Cited by
- Targeting cardiovascular disease with novel SIRT1 pathways.
Chong ZZ, Wang S, Shang YC, Maiese K. Chong ZZ, et al. Future Cardiol. 2012 Jan;8(1):89-100. doi: 10.2217/fca.11.76. Future Cardiol. 2012. PMID: 22185448 Free PMC article. Review. - FOXO Signaling Pathways as Therapeutic Targets in Cancer.
Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W. Farhan M, et al. Int J Biol Sci. 2017 Jul 6;13(7):815-827. doi: 10.7150/ijbs.20052. eCollection 2017. Int J Biol Sci. 2017. PMID: 28808415 Free PMC article. Review. - Oxidative stress: Biomarkers and novel therapeutic pathways.
Maiese K, Chong ZZ, Hou J, Shang YC. Maiese K, et al. Exp Gerontol. 2010 Mar;45(3):217-34. doi: 10.1016/j.exger.2010.01.004. Epub 2010 Jan 11. Exp Gerontol. 2010. PMID: 20064603 Free PMC article. Review. - Erythropoietin: new directions for the nervous system.
Maiese K, Chong ZZ, Shang YC, Wang S. Maiese K, et al. Int J Mol Sci. 2012;13(9):11102-11129. doi: 10.3390/ijms130911102. Epub 2012 Sep 6. Int J Mol Sci. 2012. PMID: 23109841 Free PMC article. Review. - Diabetes mellitus: channeling care through cellular discovery.
Maiese K, Shang YC, Chong ZZ, Hou J. Maiese K, et al. Curr Neurovasc Res. 2010 Feb;7(1):59-64. doi: 10.2174/156720210790820217. Curr Neurovasc Res. 2010. PMID: 20158461 Free PMC article.
References
- Chong ZZ, Li F, Maiese K. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol. 2005;75(3):207–46. - PubMed
- Hoane MR, Kaplan SA, Ellis AL. The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury. Brain Res. 2006;1125(1):185–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 ES06639/ES/NIEHS NIH HHS/United States
- R01 NS053946-01A2/NS/NINDS NIH HHS/United States
- P30 ES006639/ES/NIEHS NIH HHS/United States
- R01 NS053946-02/NS/NINDS NIH HHS/United States
- R01 NS053946/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources